Uttamchandani Mahesh, Lu Candy H S, Yao Shao Q
Defence Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Drive, Singapore 117510.
Acc Chem Res. 2009 Aug 18;42(8):1183-92. doi: 10.1021/ar9000586.
Sequencing of the human genome provided a wealth of information about the genomic blueprint of a cell. But genes do not tell the entire story of life and living processes; identifying the roles of enzymes and mapping out their interactions is also crucial. Enzymes catalyze virtually every cellular process and metabolic exchange. They not only are instrumental in sustaining life but also are required for its regulation and diversification. Diseases such as cancer can be caused by minor changes in enzyme activities. In addition, the unique enzymes of pathogenic organisms are ripe targets for combating infections. Consequently, nearly one-third of all current drug targets are enzymes. An estimated 18-29% of eukaryotic genes encode enzymes, but only a limited proportion of enzymes have thus far been characterized. Therefore, little is understood about the physiological roles, substrate specificity, and downstream targets of the vast majority of these important proteins. A key step toward the biological characterization of enzymes, as well as their adoption as drug targets, is the development of global solutions that bridge the gap in understanding these proteins and their interactions. We herein present technological advances that facilitate the study of enzymes and their properties in a high-throughput manner. Over the years, our group has introduced and developed a variety of such enabling platforms for many classes of enzymes, including kinases, phosphatases, and proteases. For each of these different types of enzymes, specific design considerations are required to develop the appropriate chemical tools to characterize each class. These tools include activity-based probes and chemical compound libraries, which are rapidly assembled using efficient combinatorial synthesis or "click chemistry" strategies. The resulting molecular assortments may then be screened against the target enzymes in high-throughput using microplates or microarrays. These techniques offer powerful means to study, profile, and discover potent small molecules that can modulate enzyme activity. This Account will describe the concepts involved in designing chemical probes and libraries for comparative enzyme screening and drug discovery applications, as well as highlight how these technologies are changing the way in which enzymes may be rapidly profiled and characterized.
人类基因组测序为细胞的基因组蓝图提供了丰富信息。但基因并不能讲述生命及生命过程的全部故事;确定酶的作用并描绘它们的相互作用同样至关重要。酶几乎催化了每一个细胞过程和代谢交换。它们不仅对维持生命至关重要,而且对生命的调节和多样化也必不可少。诸如癌症等疾病可能由酶活性的微小变化引起。此外,致病生物的独特酶是对抗感染的理想靶点。因此,目前所有药物靶点中近三分之一是酶。据估计,18 - 29%的真核基因编码酶,但迄今为止只有有限比例的酶得到了表征。因此,对于这些重要蛋白质中的绝大多数,人们对其生理作用、底物特异性和下游靶点了解甚少。酶的生物学表征以及将其用作药物靶点的关键一步是开发能够弥合对这些蛋白质及其相互作用理解差距的全局解决方案。我们在此介绍有助于以高通量方式研究酶及其性质的技术进展。多年来,我们团队为包括激酶、磷酸酶和蛋白酶在内的多种酶类引入并开发了各种此类支持平台。对于每一种不同类型的酶,都需要特定的设计考量来开发合适的化学工具以表征每一类酶。这些工具包括基于活性的探针和化合物库,它们可通过高效的组合合成或“点击化学”策略快速组装而成。然后可以使用微孔板或微阵列对所得分子组合针对目标酶进行高通量筛选。这些技术为研究、分析和发现能够调节酶活性的强效小分子提供了有力手段。本综述将描述设计用于比较酶筛选和药物发现应用的化学探针和库所涉及的概念,并强调这些技术如何改变快速分析和表征酶的方式。